The new medications, siponimod (Mayzent, Novartis) and cladribine (Mavenclad, EMD Serono), bring treatment options to active secondary progressive multiple sclerosis (SPMS). Most treatments approved for MS are for relapsing, rather than progressive, forms of the disease.
Multiple sclerosis treatment is one of the fastest moving areas of medicine.
A number of disease-modifying therapies (DMTs) are effective in decreasing the frequency of relapses and the number of lesions in the brain or spinal cord.
Patients living with multiple sclerosis (MS) in the US may try these disease-modifying therapies (DMTs) to slow down the long-term progression of the disease.
Multiple sclerosis requires you to learn large amounts of information. During pregnancy, one concern is your MS medication.
Nearly 59 percent of American adults who meet guidelines for statin therapy to lower cholesterol say their physicians hadn’t given them a statin option.